XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.890
-0.070 (-2.36%)
Apr 25, 2025, 4:00 PM EDT - Market closed
XBiotech Market Cap
XBiotech has a market cap or net worth of $88.11 million as of April 25, 2025. Its market cap has decreased by -68.79% in one year.
Market Cap
88.11M
Enterprise Value
-73.10M
1-Year Change
-68.79%
Ranking
Category
Stock Price
$2.89
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $88.11M, a decrease of -88.05%. That is a compound annual growth rate of -19.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 90.20M | -25.08% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.40B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |